Learn how health economics and early-stage technology assessment can support your research and development planning, raise capital, and help communicate your value proposition more clearly and effectively to payers. The IHE provides small- and medium-sized enterprises (SMEs) and innovation ecosystem partners with educational services to describe the importance of, and requirements…
- Chronic Diseases / Disorders
- Community Health Centres
- Fetal Alcohol Spectrum Disorder (FASD)
- Health Economics / Healthcare Costs
- Health Measurement Tools
- Health Policy
- Health Technology Assessment
- Healthcare Services
- Infectious Diseases
- Maternal and Child Health
- Mental Health
- Nurse Practitioners
- Primary Care
- Quality of Life
The outcome of IHE initiatives is providing better information for developing health policy and best medical practices. IHE disseminates information in many ways. In addition to publications in peer-reviewed journals, IHE produces books and a variety of reports synthesizing information in a particular field.
If you cannot find the publication or report you are seeking, please contact us at [email protected]. Thank you!
Refine your search by clicking filters to the left.
IHE can serve as an economic partner in the trial of new technology in order to prepare the economic component of the evidence package required for procurement. In addition to clinical data to demonstrate the safety and efficacy of a technology, life sciences small- and medium-sized enterprises (SMEs) require health economic data and analysis to demonstrate the cost-effectiveness…
Support for market-ready life sciences companies in obtaining initial market access in a jurisdiction of interest, where the company, together with the IHE as a named economic partner, is in an improved position to engage with a procuring health system and prepare the adoption case for new technology. The IHE Life Sciences Market Access Program supports Alberta-based life sciences…
Be confident in your investment decisions - evaluate the commercial potential of healthcare technology in development through the IHE Early-Stage Life Sciences Technology Assessment service. The IHE provides services for early-stage small- and medium-sized enterprise (SME) technology developers (or other innovators, such as an academic group considering forming an SME) to present…
News items are kept on the IHE website for 6 months. If you require an older news item, please contact us at [email protected] For media inquiries, please contact John Sproule, Senior Policy Director at [email protected]
Health economics evidence is not only a good business decision – it's expected. Health economics serves a critical function for life sciences small- and medium-sized enterprises (SMEs). In addition to clinical data demonstrating safety and efficacy, SMEs require health economics data and analysis to demonstrate that their innovations are cost-effective for health systems and represent…